Vivanza Biosciences signs strategic cooperation agreement for Kyrgyz film project
Vivanza Biosciences Limited has entered into a Strategic Cooperation, Investment & Technology Transfer Agreement with Mr. Kalybek Uulu Bekturgan for a Plastic Film Manufacturing Project in the Kyrgyz Republic. The non-binding agreement encompasses technology transfer, investment facilitation, and potential joint venture formation. No monetary consideration was paid initially, and the company expects the move to enhance its international presence and export markets.

*this image is generated using AI for illustrative purposes only.
Vivanza Biosciences Limited has signed a Strategic Cooperation, Investment & Technology Transfer Agreement with Mr. Kalybek Uulu Bekturgan to establish a Plastic Film Manufacturing Project in the Kyrgyz Republic. The international agreement aims to strengthen the company's presence in the region through industrial cooperation and technology transfer. No monetary consideration was exchanged at the signing of this non-binding pact.
The agreement outlines a scope of work that includes technology transfer, project design and implementation support, machinery sourcing, and government liaison. It also provides for investment facilitation, skill development, import-export promotion, and financing assistance. The parties may explore the possibility of establishing a Joint Venture Company, subject to the execution of definitive agreements and necessary approvals.
Key Agreement Details
| Particulars | Details |
|---|---|
| Name of Entity | Vivanza Biosciences Limited and Mr. Kalybek Uulu Bekturgan |
| Area of Agreement | Strategic cooperation for establishment of Plastic Film Manufacturing Project |
| Location | Kyrgyz Republic |
| Consideration | No monetary consideration at present |
| Related Party Transaction | Not Applicable (N.A.) |
The company expects the arrangement to facilitate international industrial cooperation and expand export markets. While the agreement is intended to create long-term growth opportunities, the company noted that no immediate financial benefit can be quantified due to the non-binding nature of the pact. Vivanza Biosciences will disclose any termination of the arrangement to the stock exchange in accordance with SEBI regulations.
Historical Stock Returns for Vivanza Biosciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.50% | +11.30% | +11.30% | -5.29% | -7.08% | -82.87% |
What is the projected timeline for executing definitive agreements and establishing the Joint Venture Company?
How will Vivanza Biosciences secure the necessary financing for the project given no monetary consideration was exchanged upfront?
What specific regulatory approvals from the Kyrgyz Republic government are required before operations can commence?































